Abstract
Synthetic biology is the new emerging discipline of science which combines principles of engineering with biology to redesign a living system to produce something it would not naturally produce. The living cells will alter through recombinant DNA technology to meet specific purposes. Since, fungi are themselves established cell factories in pharmaceutical industry. The versatile chemical entities secreted by these organisms have tremendous benefits. The need of the hour is to club synthetic biology and mycology to enhance gains. The great success of synthetic biology in the field of bio-production with the success story of artemisinin will likely influence the early stages of drug discovery. Next future interests are likely in the rational design of new biochemicals through genetic shuffling of biosynthetic modules in order to be compliant with large-scale production within microorganisms. However, it is also possible to anticipate technical constraints (current efficiency) as the majority of work performed in synthetic biology is in basic science rather than applied science to understand fundamental processes. Majority of projects were centered on developing new experimental and computational tools, using synthetic biology to understand how organism work or to generate minimal cells that can be counted as time constraint as it is also evident in case of semi-artiseminin where it took 10 long years. New molecular compounds as well as hosts were formed and manipulated for human benefit. Engineered systems are rapidly becoming a reality which is based on advances in our ability to edit genome and identify and optimize biosynthetic building blocks. This can help in creating a library of new pathways and novel compounds. But at the same time, ethical issues centered about the complete engineering of a new living organism or redesigning of existing species caught negative attention. It may or may not create problem but danger of evolving a new virulent strains always crossed in mind. Anyways, bolder initiatives are needed in funding for using this technology as it will be benefitted by the advancement of computational and engineering technology which in the future will move many more examples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adrio JL, Demain AL (2003) Fungal biotechnology. Int Microbiol 6:191–199
Ajikuar PK, Xiao WH, Tyo KEJ, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Steohanopoulos (2010) Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330:70–73
Andrianantoandro E, Basu S, Karig DK, Weiss R (2006) Synthetic biology: new engineering rules for an emerging discipline. Mol Syst Biol 2:0028
Awan AR, Blount BA, Bell DJ, Shaw WM, McKiernan RM, Ellis T (2017) Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker’s yeast. Nat Commun 8:15202
Barrios-Gonz AJ, Miranda RU (2010) Biotechnological production and applications of statins. Appl Microbiol Biotechnol 85:869–883
Ben-Ari G, Zenvirth D, Sherman A, David L, Klutstein M, Layi U, Hillel J, Simchen G (2006) Four linked genes participate in controlling sporulation efficiency in budding yeast. PLoS Genet 2:e195
Berdy J (2005) Bioactive microbial metabolites. J Antibiot 58:1–26
Bertea CM (2005) Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Med 71:40–47
Bertea CM, Voster A, Verstappen FW, Mattei M, Beekwilder J, Bouwmeester HJ (2006) Isoprenoid biosynthesis in Artemisia cloning: Cloning and heterologous expression of a germocrene A synthase from a glandular trichome DNA library. Arch Biochem Biophys 448(1–2):3–12
Bouwmeester HJ, Wallaart TE, Janssen MH, van Loo B, Jansen BJ, Posthumus MA, Schmidt CO, De Kraker JW, König WA, Franssen MC (1999) Amorpha-4,11-diene synthase catalyses the first probable step in artemisinin biosynthesis. Phytochemistry 52:843–854
Breitling R, Takano E (2015) Synthetic biology advances for pharmaceutical production. Curr Opin Biotechnol 35C:46–51
Brown GD (2010) The biosynthesis of artemisinin (Qinghaosu) and the phytochemistry of Artemisia annua L. (Qinghao). Molecules 15:7603–7698
Chakravarthi BV, Das P, surendranath K, Karande AA, Jayabaskaran C (2008) Production of paclitaxel by Fusarium solani isolated from Taxus celebica. J Biosci 33:259–267
Covello PS, Teoh KH, Polichuk DR, Reed DW, Nowak G (2007) Functional genomics and the biosynthesis of artemisinin. Phytochemistry 68:1864–1871
Croteau R, Raymond E, Ketchum B, Long RM, Kaspera R (2006) Wildung. Taxol biosynthesis and molecular genetics Phytochem Rev 5:75–97
Currie JN (1917) The citric acid fermentation of Aspergillus Niger. J Biol Chem 31:15
DeJong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D, Croteau RB (2005) Genetic engineering of Taxol biosynthetic genes in Saccharamyces cereviseae. Biotechnol Bioeng 93:221–224
Engels B, Dahm P, Jennewein S (2008) Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (paclitaxel) production. Metab Eng 10:201–206
Finkelstein E, Amichai B, Grunwald MH (1996) Griseofulvin and its uses. Int J Antimicrob Agents 6:189–194
Flores-Bustamante ZR, Rivera-Orduña FN, Martínez-Cárdenas A, Flores-Cotera LB (2010) Microbial paclitaxel: advances and perspectives. J Antibiot 63:460–467
Frasch HJ, Medema MH, Takano E, Breitling R (2013) Design based reengineering of biosynthetic gene clusters: plug-and-play-in practice. Curr Opin Biotechnol 24:1144–1150
Garyali S, Kumar A, Reddy MS (2013) Taxol production by an endophytic fungus, Fusarium redolens, isolated from Himalayan yew. J Microbiol Biotechnol 23:1372–1138
Guo BH, Wang YC, Zhou XW, Hu K, Tan F, Miao ZQ, Tang KX (2006) An endophytic Taxol-producing fungus BT2 isolated from Taxuschinensis var. mairei. Afr J Biotechnol 5:875–877
Hao X (2013) Taxol producing fungi. In: Ramawat KG, Merillon JM (eds) Natural products. Springer-Verlag, pp 2797–2812
Hawkins KM, Smolke CD (2008) Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nature Chem Biol 4:564–573
Hayden EC (2014) Synthetic biology firms shift focus. Nature 505:598
Helfrich EJN, Reiter S, Piel J (2014) Recent advances in genome based polyketide discovery. Curr Opin Biotechnol 29:107–115
Huang Q, Roessner CA, Croteau R, Scott AI (2001) Engineering Escherichia coli for the synthesis of Taxadiene, a key intermediate in the biosynthesis of Taxol. Biorg Med Chem 9:2237–2242
Jaitzig J, Li J, Sussmuth RD, Neubauer P (2014). Reconstituted biosynthesis nonribosomal macrolactone antibiotic valinomycin in E.coli. Acs Synth Biol 18;3(7):432–438
Jennewein S, Croteau R (2001) Taxol biosynthesis: molecular genetics and biotechnological applications. Appl Microbiol Biotechnol 57:13–19
Jiang M, Stephanopoulos G, Pfeifer BA (2012) Downstream reactions and engineering in the microbially reconstituted pathway for Taxol. Appl Microbiol Biotechnol 94:841–849
Kai Z, Ping W, Zhang L, Liu J, Lin Y, Jin T, Zhou D (2008) Screening and breeding of high Taxol producing fungi by genome shuffling. Sci China C Life Sci 51:222–231
Kinoshita S, Udaka S, Shimino M (1957) Studies on the amino acid fermentation. Part I. Production of L-glutamic acid by various organisms. J Gen Appl Microbiol 3:193–205
Kitano H (2002) Computational systems biology. Nature 420:206–210
Komatsu M, Komatsu K, Koiwai H, Yamada Y, Kozone I, Izumikawa M, Hashimoto J, Takagi M, Omura S, Shin-Ya K (2013) Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites. ACS Synth Biol 2013(2):384–396
Lee TS, Khosla C, Tang Y (2005) Engineered biosynthesis of aklanonic acid analogues. J Am Chem Soc 127:12254–12262
Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotech 21:796–802
Medema MH, Breitling R, Bovenberg R, Takano E (2011) Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms. Nat Rev Microbiol 9:131–137
Medema MH, Kottmann R, Yilmaz P (2015) Minimum information about a biosynthetic gene cluster. Nat Chem Biol 11(9):625–631
Meng H, Wang Y, Hua Q, Zhang S, Wang X (2011) In silico analysis and experimental improvement of taxadiene heterologous biosynthesis in Escherichia coli. Biotechnol Bioprocess Eng 16:205–215
Miao Z, Wang Y, Yu X, Guo B, Tang K (2009) New endophytic taxane production fungus from T. chinensis. Appl Biochem Microbiol 45:81–86
Minami H, Kim JS, Ikezawa N, Takemura T, Katayama T, Kumagai H, Sato F (2008) Microbial production of plant benzylisoquinoline alkaloids. Proc Natl Acad Sci U S A 105:7393–7398
Mutka SC, Carney JR, Liu Y, Kennedy J (2006) Heterologous production of epothilone C and D in Escherichia coli. Biochemistry 45:1321–1313
Naesby M, Nielsen SV, Nielsen CA, Green T, Tange TO, Simón E (2009) Yeast artificial chromosomes employed for random assembly of biosynthetic pathways and production of diverse compounds in Saccharomyces cerevisiae. Microb Cell Factories 8:45
Nielsen J, Keasling JD (2016) Engineering Cellular Metabolism Cell 164:1185–1197
Nikel PI (2014) Martı’nez-Garcı’a E, De Lorenzo V. Biotechnological domestication of pseudomonads using synthetic biology Nat Rev Microbiol 12:368–379
Paddon CJ, Keasling JD (2014) Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 12(5):355
Paddon CJ, Westfall PJ, Pitera DJ, Benjamin K, Fisher K, McPhee D, Leavell MD, Tai A, Main A, Eng D (2013) High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496:528–532
Pfeifer B, Hu Z, Licari P, Khosla C (2002) Process and metabolicstrategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B. Appl Environ Microbiol 68:3287–3292
Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C (2001) Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291:1790–1792
Pitera DJ, Paddon CJ, Newman JD, Keasling JD (2007) Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng 9:193–207
Reiling KK, Yoshikuni Y, Martin VJ, Newman J, Bohlmann J, Keasling JD (2004) Mono and diterpene production in Escherichia coli. Biotechnol Bioeng 87:200–212
Ro DK, Yoshikuni Y, Martin VJ, Newman J, Bohlmann J, Keasling JD (2008) Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnol 8:83
Rude MA, Khosla C (2006) Production of ansamycin polyketide precursors in Escherichia coli. J Antibiot 59:464–470
Rugbjerg P, Naesby M, Mortensen UH, Frandsen RJN (2013) Reconstruction of the biosynthetic pathway for the core fungal polyketide scaffold rubrofusarin in Saccharomyces cerevisiae. Microb Cell Factories 12:31. https://doi.org/10.1186/1475-2859-12-31
Shao Z, Rao G, Li C, Abil Z, Luo Y, Zhao H (2013) Refactoring the silent spectinabilin gene cluster using a plug-and-play scaffold. ACS Synth Biol 2:662–669
Staniek A, Bouwmeester H, Fraser PD, Kayser O, Martens S, Tissier A, van der Krol S, Wessjohann L, Warzecha H (2013) Natural products-modifying metabolite pathways in plants. Biotechnol J 8:1159–1171
Staniek A, Woerdenbag HJ, Kayser O (2009) Taxomycesandreanae: a presumed paclitaxel producer demystified. Planta Med 75:1561–1566
Stassen PM, Kallenberg CGM, Stegeman CA (2007) Use of mycophenolic acid in non-transplant renal diseases. Nephrol Dial Transpl 22:101–109
Sun H, Liu Z, Zhao H, Ang EL (2015) Recent advances in combinatorial biosynthesis for drug discovery. Drug Des Devel Ther 9:823–833
Suryanarayanan TS, Thirunavukkarasu N, Govindarajulu MB, Sasse F, Jansen R, Murali TS (2009) Fungal endophytes and bioprospecting. Fungal Biol Rev 23:9–19
Teoh KH, Polichuk DR, Reed DW, Covello PS (2009) Molecular cloning of an aldehyde dehydrogenase implicated in artemisinin biosynthesis in Artemisia annua. Botany 87:635–642
Thykaer J, Nielsen J (2003) Metabolic engineering of beta-lactam production. Metab Eng 5:56–69
Trosset JY, Carbonell P (2015) Synthetic biology for pharmaceutical drug discovery. Drug Des Devel Ther 3(9):6285–6302
vanDijken JP, Bauer J, Brambilla L, Duboc P, Francois JM, Gancedo C (2000) An interlaboratory comparison of physiological and genetic properties of four Saccharomyces cerevisiae strains. Enzym Microb Technol 26:706–714
Walker K, Croteau R (2001) Taxol biosynthetic genes. Phytochemistry 58:1–7
Watanabe K, Rude MA, Walsh CT, Khosla C (2003) Engineered biosynthesis of an ansamycinpolyketide precursor in Escherichia coli. Proc Natl Acad Sci U S A 100:9774–9778
Wei Y, Liu L, Zhou X, Lin J, Sun X, Tang K (2012) Engineering Taxol biosynthetic pathway for improving Taxol yield in Taxol-producing endophytic fungus EFY-21 (Ozonium sp.). Afr J Biotechnol 11:9094–9101
Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R (2012) Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 109:E111–E118
White NJ (2008) Qinghaosu (artemisinin): the price of success. A review of the history and properties of artemisinin. Science 320:330–334
Wilson MC, Piel J (2013a) Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology. Chem Biol 20:636–647
Wilson MC, Piel J (2013b) Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology. Chem Boil 20:636–647
Wilson SA, Cummings EM, Roberts SC (2014) Multi-scale engineering of plant cell cultures for promotion of specialized metabolism. Curr Opin Biotechnol 29:163–170
Xiong ZQ, Yang YY, Zhao N, Wang Y (2013) Diversity of endophytic fungi and screening of fungal paclitaxel producer from Anglojap yew, Taxus x media. BMC Microbiol. https://doi.org/10.1186/1471-2180-13-71
Yang Y, Zhao H, Barrero RA, Zhang B, Sun G, Wilson IW, Xie F, Walker KD (2014) Genome sequencing and analysis of the paclitaxel-producing endophytic fungus Penicillium aurantiogriseum NRRL 62431. BMC Gen 15:69. https://doi.org/10.1186/1471-2164-15-69
Zhang P, Zhou PP, Yu LJ (2009) An endophytic Taxol-producing fungus from Taxus x media, Aspergillus candidus MD3. FEMS Microbiol Lett 293:155–159
Zhang W, Li Y, Tang Y (2008) Engineered biosynthesis of bacterial aromatic polyketides in Escherichia coli. Proc Natl Acad Sci U S A 105:20683–20688
Zhao L, Chang WC, Xiao Y, Liu HW, Liu P (2013) Methylerythritol phosphate pathway of isoprenoid biosynthesis. Annu Rev Biochem 82:497–530
Zhu F, Zhong X, Hu M, Lu L, Deng Z, Liu T (2014) In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli. Biotechnol Bioeng 111:1396–1405
Acknowledgments
The authors are grateful to the Department of Molecular Biology, Biotechnology & Bioinformatics, CCS Haryana Agricultural University, Hisar; and Department of Genetics & Plant Breeding, GB Pant University of Agriculture & Technology, Pantnagar for providing the facilities and financial support, to undertake the investigations. There are no conflicts of interest.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rashmi, Kumar, U., Maan, P., Priyanka (2019). Synthetic Biology: A Novel Approach for Pharmaceutically Important Compounds. In: Yadav, A., Singh, S., Mishra, S., Gupta, A. (eds) Recent Advancement in White Biotechnology Through Fungi. Fungal Biology. Springer, Cham. https://doi.org/10.1007/978-3-030-14846-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-14846-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14845-4
Online ISBN: 978-3-030-14846-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)